This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Alexey Kuznetsov: Innovator in Cancer Treatment
Introduction
Alexey Kuznetsov is a notable inventor based in Nashville, TN, who has made significant contributions to the field of cancer research. His work focuses on developing innovative compounds that can inhibit specific interactions related to cancer cell proliferation.
Latest Patents
Kuznetsov holds a patent for WDR5-MYC inhibitors, which are substituted N-phenyl sulfonamide compounds. These compounds are designed to inhibit WDR5-MYC interactions, providing potential therapeutic benefits for treating various disorders, particularly in the context of cancer.
Career Highlights
Kuznetsov is affiliated with Vanderbilt University, where he engages in cutting-edge research aimed at advancing cancer treatment methodologies. His dedication to innovation in this field has positioned him as a key figure in the scientific community.
Collaborations
He has collaborated with esteemed colleagues such as William P. Tansey and Stephen W. Fesik, contributing to a collaborative environment that fosters groundbreaking research and development.
Conclusion
Alexey Kuznetsov's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile